论文部分内容阅读
在早期乳腺癌(ESBC)如淋巴结阴性乳腺癌患者的治疗中,辅助化疗使远处转移和死亡风险降低了约50%。医师根据一些临床病理诊断标准来判断是否ESBC患者需要接受辅助内分泌治疗和/或化疗。目前ESBC的治疗指南
Adjuvant chemotherapy reduced the risk of distant metastases and death by about 50% in the treatment of patients with early-stage breast cancer (ESBC) such as node-negative breast cancer. Physicians judge whether ESBC patients require adjuvant endocrine therapy and / or chemotherapy based on some clinicopathological criteria. Current ESBC treatment guidelines